Last reviewed · How we verify

ginsenoside RE — Competitive Intelligence Brief

ginsenoside RE (ginsenoside RE) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Natural product/herbal extract. Area: General wellness/Adaptogenic.

marketed Natural product/herbal extract General wellness/Adaptogenic Small molecule Live · refreshed every 30 min

Target snapshot

ginsenoside RE (ginsenoside RE) — Washington University School of Medicine. Ginsenoside RE is a natural triterpenoid saponin from ginseng that modulates multiple cellular pathways including stress response, anti-inflammatory, and antioxidant mechanisms.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ginsenoside RE TARGET ginsenoside RE Washington University School of Medicine marketed Natural product/herbal extract

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Natural product/herbal extract class)

  1. Washington University School of Medicine · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ginsenoside RE — Competitive Intelligence Brief. https://druglandscape.com/ci/ginsenoside-re. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: